Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. is a revenue stage medical technology and healthcare services company that provides a comprehensive suite of proprietary oral appliances and therapeutic treatments. The company's products non-surgically treat certain maxillofacial and developmental abnormalities of the mouth and jaws linked to breathing and sleep disorders, including mild to severe obstructive sleep apnea (OSA) and snoring in adults. This approach, called The Vivos Method, combines the use of their appliances with specific therapeutic treatment protocols. The Vivos Method is estimated to be indicated and potentially effective in approximately 80% of OSA cases where patients comply with clinical treatments, within the scope of FDA cleared uses. Vivos's patented C.A.R.E. oral appliances have been used by approximately 60,000 patients treated worldwide by over 2,000 trained dentists. Their other lines of oral appliances have treated an estimated additional 15,000 or more patients globally. Since 2024, the company has been shifting its business model to generate revenue from appliance sales and the provision of healthcare services. This involves acquiring and managing sleep medical practices that diagnose and treat OSA, and establishing Vivos-supported and managed Dental and Medical Service Organizations (DSOs and MSOs). The company has started branding its OSA treatment business as Sleep and Airway Medicine Centers (SAMC). The Vivos Method now includes a broader range of product and service lines beyond the proprietary technologies in their C.A.R.E. appliances.